Tom Heyman is the Global Head of Business Development, Pharmaceuticals Group of Janssen Global Services, LLC. In this role, he is responsible for all of the licensing and acquisition activities in this group. The Johnson & Johnson Development Corporation reports to Tom. He is also a member of the Group Operating Committee of the Janssen Group.
In addition to this role, in November 2008, Tom was named Chief Executive Officer, Janssen Pharmaceutica NV in Belgium. He also was appointed Chairman of the Janssen Pharmaceutica NV Board of Directors in March 2012. Tom is a member of the Board of Directors VOKA, the Flemish Industry Association, Belgium, and member of the Board of Directors of Innotek. As of April 2012, he is a member of the Board of Directors and the General Assembly of IMEC.
Tom started his career with the Johnson & Johnson Family of Companies in the Legal Department of Janssen Pharmaceutica in 1982, where he held a management position supporting legal and licensing activities. In 1990, he became Vice-President of Corporate Development at Ortho Pharmaceutical Corporation, and was appointed Head of Global Business Development for the Pharmaceutical Group in 1992. From June 2007 until July 2009, he also served as Head of the Central Nervous System/Internal Medicine Research & Early Development (RED) organization.
Tom holds a Master of Law degree from the Katholieke Universiteit Leuven in Belgium. He continued with post-graduate studies in International Law in Geneva, Switzerland, and post-graduate studies in Business Management at the University of Antwerp in Belgium.